CJC-1295 with DAC is a synthetic peptide that stimulates growth hormone release, promoting muscle growth, fat loss, and cellular repair.
Overview
CJC-1295 with DAC (Drug Affinity Complex) is a modified growth hormone-releasing hormone (GHRH) analog. It is designed to increase the body’s natural production of growth hormone by stimulating the pituitary gland. The addition of DAC allows the peptide to stay active in the body for an extended period, offering longer-lasting benefits compared to non-DAC versions.
By boosting growth hormone levels over a sustained period, CJC-1295 with DAC supports muscle development, fat metabolism, skin rejuvenation, and overall recovery. It is primarily used in anti-aging therapies, sports performance enhancement, and certain research-based metabolic treatments.
Research
Studies have shown that CJC-1295 with DAC significantly elevates growth hormone and IGF-1 (Insulin-like Growth Factor 1) levels for up to 14 days after a single injection. This makes it a convenient alternative to daily hormone therapies, with long-lasting effects on metabolism and tissue regeneration.
In research environments, CJC-1295 with DAC has demonstrated potential benefits in improving lean body mass, enhancing sleep quality, and accelerating healing. While widely studied in clinical and athletic settings, it is still under investigation for safety and efficacy in long-term human use.
Reviews
There are no reviews yet.